Activation of cyclic GMP-AMP synthase by self-DNA causes autoimmune diseases
- PMID: 26371324
- PMCID: PMC4620884
- DOI: 10.1073/pnas.1516465112
Activation of cyclic GMP-AMP synthase by self-DNA causes autoimmune diseases
Abstract
TREX1 is an exonuclease that digests DNA in the cytoplasm. Loss-of-function mutations of TREX1 are linked to Aicardi-Goutieres Syndrome (AGS) and systemic lupus erythematosus (SLE) in humans. Trex1(-/-) mice exhibit autoimmune and inflammatory phenotypes that are associated with elevated expression of interferon (IFN)-induced genes (ISGs). Cyclic GMP-AMP (cGAMP) synthase (cGAS) is a cytosolic DNA sensor that activates the IFN pathway. Upon binding to DNA, cGAS is activated to catalyze the synthesis of cGAMP, which functions as a second messenger that binds and activates the adaptor protein STING to induce IFNs and other cytokines. Here we show that genetic ablation of cGas in Trex1(-/-) mice eliminated all detectable pathological and molecular phenotypes, including ISG induction, autoantibody production, aberrant T-cell activation, and lethality. Even deletion of just one allele of cGas largely rescued the phenotypes of Trex1(-/-) mice. Similarly, deletion of cGas in mice lacking DNaseII, a lysosomal enzyme that digests DNA, rescued the lethal autoimmune phenotypes of the DNaseII(-/-) mice. Through quantitative mass spectrometry, we found that cGAMP accumulated in mouse tissues deficient in Trex1 or DNaseII and that this accumulation was dependent on cGAS. These results demonstrate that cGAS activation causes the autoimmune diseases in Trex1(-/-) and DNaseII(-/-) mice and suggest that inhibition of cGAS may lead to prevention and treatment of some human autoimmune diseases caused by self-DNA.
Keywords: DNaseII; Trex1; autoimmune disease; cGAMP; cGAS.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Comment in
-
cGMP-AMP synthase paves the way to autoimmunity.Proc Natl Acad Sci U S A. 2015 Oct 20;112(42):12903-4. doi: 10.1073/pnas.1517578112. Epub 2015 Oct 8. Proc Natl Acad Sci U S A. 2015. PMID: 26450878 Free PMC article. No abstract available.
Similar articles
-
Inhibition of Cyclic GMP-AMP Synthase Using a Novel Antimalarial Drug Derivative in Trex1-Deficient Mice.Arthritis Rheumatol. 2018 Nov;70(11):1807-1819. doi: 10.1002/art.40559. Epub 2018 Sep 14. Arthritis Rheumatol. 2018. PMID: 29781188
-
Cutting Edge: cGAS Is Required for Lethal Autoimmune Disease in the Trex1-Deficient Mouse Model of Aicardi-Goutières Syndrome.J Immunol. 2015 Sep 1;195(5):1939-43. doi: 10.4049/jimmunol.1500969. Epub 2015 Jul 29. J Immunol. 2015. PMID: 26223655 Free PMC article.
-
cGAS activation in classical dendritic cells causes autoimmunity in TREX1-deficient mice.Proc Natl Acad Sci U S A. 2024 Sep 17;121(38):e2411747121. doi: 10.1073/pnas.2411747121. Epub 2024 Sep 10. Proc Natl Acad Sci U S A. 2024. PMID: 39254994 Free PMC article.
-
Emerging role of the cGAS-STING signaling pathway in autoimmune diseases: Biologic function, mechanisms and clinical prospection.Autoimmun Rev. 2022 Sep;21(9):103155. doi: 10.1016/j.autrev.2022.103155. Epub 2022 Jul 25. Autoimmun Rev. 2022. PMID: 35902046 Review.
-
A STING to inflammation and autoimmunity.J Leukoc Biol. 2019 Jul;106(1):171-185. doi: 10.1002/JLB.4MIR1018-397RR. Epub 2019 Apr 16. J Leukoc Biol. 2019. PMID: 30990921 Review.
Cited by
-
DNA-sensing pathways in health, autoinflammatory and autoimmune diseases.Nat Immunol. 2024 Nov;25(11):2001-2014. doi: 10.1038/s41590-024-01966-y. Epub 2024 Oct 4. Nat Immunol. 2024. PMID: 39367124 Review.
-
AARS1 and AARS2 sense L-lactate to regulate cGAS as global lysine lactyltransferases.Nature. 2024 Oct;634(8036):1229-1237. doi: 10.1038/s41586-024-07992-y. Epub 2024 Sep 25. Nature. 2024. PMID: 39322678
-
TBK1-Zyxin signaling controls tumor-associated macrophage recruitment to mitigate antitumor immunity.EMBO J. 2024 Sep 20. doi: 10.1038/s44318-024-00244-9. Online ahead of print. EMBO J. 2024. PMID: 39304793
-
QnAs with Zhijian "James" Chen: Winner of the 2024 Albert Lasker Basic Medical Research Award.Proc Natl Acad Sci U S A. 2024 Sep 24;121(39):e2415810121. doi: 10.1073/pnas.2415810121. Epub 2024 Sep 19. Proc Natl Acad Sci U S A. 2024. PMID: 39297684 Free PMC article. No abstract available.
-
Monogenic lupus - from gene to targeted therapy.Mol Cell Pediatr. 2024 Sep 12;11(1):8. doi: 10.1186/s40348-024-00181-x. Mol Cell Pediatr. 2024. PMID: 39264482 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials